The lower rate of TERT promoter mutations in HBV-related HCC could be partially explained by the frequent insertion of HBV DNA in the TERT promoter serving as additional mechanism inducing telomerase transcription (Nault et al., 2013). The gene discussed is TERT; the disease is hepatocellular carcinoma.